Multidisciplinary CNS Metastasis Update 2021

October 9, 2021

This activity will present a multidisciplinary approach to the clinical management of CNS metastasis from various cancers, discuss available innovative clinical trial options, and provide the latest updates on current techniques in neurosurgical advancements in this arena. Using a disease-oriented multiple specialty approach along with panel discussions, the activity will offer a comprehensive update for providers from multiple disciplines. Physicians and other healthcare providers locally, regionally, and nationally will learn from specialists in the field about novel advances in the treatment and management of brain and spine metastasis from common cancers encountered in daily practice. This course is intended to encourage broader collaboration, increase patient base for clinical trials, and bring established providers up to date on the latest developments in the field. Participation is encouraged through question and answer opportunities throughout the program.

Practice Gaps and Needs

Multidisciplinary CNS metastasis update is thes premier educational event in the region designed to educate a broader oncology committee involved in caring for cancer patients with brain and spine metastasis.

Elements of Competence

This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties' areas of patient care and procedural skills, medical knowledge, and interpersonal and communication skills.

This activity also focuses on the interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork and the Diversity, Equity, and Inclusion competency of valuing diversity in the clinical encounter. 

Intended Audience

This activity is designed to educate community general practitioners, oncologists, radiation oncologists, neurosurgeons, advanced practice nurses, PAs, RNs and other healthcare providers on topics relevant to new advances in the diagnosis and treatment of brain and spine metastasis from cancer.

Highlights include:

  • Updates of minimally invasive neurosurgery
  • Updates of medical/radiation oncology clinical trials

Learning Objectives

At the conclusion of this CE activity, participants will be able to:

  • Describe effective communication and collaboration with partners in care of patients with CNS metastasis.
  • Review updates and best current multidisciplinary treatment strategies for cancer patients with CNS metastasis.
  • Discuss patient-centered practice management techniques for patients with CNS metastasis.
  • Identify issues important to patients for overall quality of life from a patient's perspective.
  • List innovative clinical trials available for CNS metastasis and their eligibility criteria.

Provided by

University of Wisconsin Continuing Education Partnership & Medical College of Wisconsin

Course summary
Available credit: 
  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 ANCC Contact Hours
  • 8.00 University of Wisconsin–Madison Continuing Education Hours
    • 8.00 Approved for AMA PRA Category 1 Credit™
Registration opens: 
08/30/2021
Course expires: 
11/27/2021
Event starts: 
10/09/2021 - 7:45am CDT
Event ends: 
10/09/2021 - 5:00pm CDT
Cost:
$50.00
Add to calendar: 
Rating: 
0

Saturday, October 9, 2021

All times listed are Central Daylight Time (CDT) 

7:45 AM

Welcome

Dr. Christopher J. Schultz -- Chair, Medical College of Wisconsin
Department of Radiation Oncology


Dr. Robert J. Dempsey -- Chair, University of Wisconsin-Madison
Department of Neurological Surgery


Co-directors Dr. Joseph Bovi and Dr. Mahua Dey

Brain Metastases Update
Moderators: Joseph Bovi, MD and Mahua Dey, MD

8:00 AM

Personalized Radiotherapy Management of Brain Metastases
Vinai Gondi, MD

8:30 AM

Therapeutic Advances for Brain Metastases
Manmeet Ahluwalia, MD

9:00 AM

LITT for progressing brain metastases
Ganesh Rao, MD

9:20 AM

Imaging of Brain Metastases
Timothy Kaufmann, MD

9:50 AM

Panel Discussion

10:00 AM

BREAK

Spine Metastases Update
Moderators: Joseph Bovi, MD and Mahua Dey, MD

10:10 AM

Update on the evidence supporting spine SBRT
Arjun Sahgal, MD

10:45 AM

Neurosurgical Management of Spine Metastasis
Jean-Peal Wolinsky, MD

11:15 AM

Impact of systemic anticancer therapies on spinal metastatic disease
Ankush Bhatia, MD

11:45 AM

Metastasis of Unknown Origin: The Pathologist’s Approach to Diagnosis and Ancillary Testing
Dylan Coss, MD

12:15 PM

Panel Discussion

12:25 PM

LUNCH 

Targeted Therapy Update
Moderators: Joseph Bovi, MD and Mahua Dey, MD

1:00 PM

Precision Medicine Approaches for Patients with Brain Metastases
Priscilla Brastianos, MD

1:30 PM

Updates in Neoadjuvant SRS
Erin Murphy, MD

2:00 PM

Tumor-associated cell free nucleic acids in patient cerebrospinal fluid
Melanie Hayden Gephart MD

2:30 PM

Panel Discussion

2:40 PM

BREAK

Palliative and Supportive Care
Moderators: Joseph Bovi, MD and Mahua Dey, MD

2:50 PM

Leptomeningeal Disease: Past Experience and Future Directions
Priya Kumthekar, MD

3:20 PM

Neuropsychological Sequelae of Brain Mets and Their Treatment
Jeffrey Wefel, PhD

3:50 PM

Prognosis, palliative care, and medical assistance in dying patients with brain tumors
Jerome Graber, MD

4:20 PM

Every Day is a Bonus: Living with Kidney Cancer
Mike Hamann

4:40 PM

Panel Discussion

4:50 PM

Final Remarks 

5:00 PM

ADJOURN

 

THIS IS A VIRTUAL CONFERENCE (CENTRAL DAYLIGHT TIME). PLEASE SEE THE PROGRAM FOR FURTHER INFORMATION.

A LINK TO THE WEBINAR WILL BE SENT TO PARTICIPANTS PRIOR TO THE ACTIVITY START DATE.

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

Name

Role

Financial Relationship Disclosures

Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation?

Mahua Dey, MD

Planner/Clinical Director

No relevant financial relationships to disclose.

No

Joseph Bovi, MD

Planner

No relevant financial relationships to disclose.

No

Jessica Leiberg, DNP

Planner

No relevant financial relationships to disclose.

No

Manmeet Ahluwalia, MD, MBA

Speaker/Presenter

Astrazeneca (Grant),  BMS (Grant),  Bayer (Grant/Contractor), Incyte (Grant), Pharmacyclics (Grant), Novocure (Grant/Contractor),  Mimivax (Grant/Stock), Merck (Grant),   Kiyatec (Contractor),  Insightec (Contractor),  GSK (Contractor),  Xoft (Contractor), Nuvation (Contractor), Cellularity (Contractor),  SDP Oncology (Contractor),  Apollomics (Contractor),  Prelude (Contractor), Janssen (Contractor),  Forma Therapeutics (Contractor),  Tocagen (Contractor),  Voyager Therapeutics (Contractor),  Viewray (Contractor), Doctible (Stock), Cytodyn (Stock), MedINnovate Advisors, LLC (Stock)

Yes

Ankush Bhatia, MD

Speaker/Presenter

No relevant financial relationships to disclose.

No

Priscilla Brastianos, MD

Speaker/Presenter

Voyager (Contractor), Pfizer (Contractor), Bristol-Myers Squibb (Grant), Mirati (Grant), Dantari (Contractor), Eli Lilly and Company (Grant), SK Life Science, Inc. (Contractor), Merck (Grant), ElevateBio (Contractor), Sintetica (Contractor)

Yes

Dylan Coss, MD

Speaker/Presenter

No relevant financial relationships to disclose.

No

Jerome Graber, MD, MPH

Speaker/Presenter

American Society of Neuroimaging (Contractor)

Yes

Vinai Gondi, MD

Speaker/Presenter

No relevant financial relationships to disclose.

No

Michael Hamann

Speaker/Presenter

No relevant financial relationships to disclose.

No

Melanie Hayden Gephart, MD

Speaker/Presenter

Quadriga (Grant)

Yes

Timothy Kaufmann, MD

Speaker/Presenter

SpineThera (Stockoption)

Yes

Priya Kumthekar, MD

Speaker/Presenter

Affinia (Contractor), Orbus Therapeutics (Contractor), Utility Patient for ANG1005 for leptomeningeal disease (Patent), Novocure Inc. (Contractor), Sintetica (Contractor), Janssen Biotech (Contractor), SDP Oncology (Contractor), Enclear (Contractor), Biocept (Contractor)

No

Erin Murphy, MD

Speaker/Presenter

No relevant financial relationships to disclose.

No

Ganesh Rao, MD

Speaker/Presenter

Monteris Medical Corporation (Contractor)

No

Arjun Sahgal, MD

Speaker/Presenter

Elekta (Contractor/Travel), Varian Medical Systems (Grant/Contractor/Travel), Medtronic (Contractor), AstraZeneca (Contractor), Brainlab, Inc. (Contractor/Travel), International Stereotactic Radiosurgery Society (ISRS) (Contractor), Elekta Instrument AB (Grant), AO Spine Knowledge Forum Tumor (Contractor), Elekta Instrument AB (Contractor),

No

Jeffrey Wefel, PhD

Speaker/Presenter

GT Medical Technologies, Inc (Institution: Contractor), Juno (Institution: Contractor), Vanquish Oncology (Contractor), Angiochem (Contractor), Bayer HealthCare Pharmaceuticals Inc. (Institution: Contractor), Novocure Inc. (Institution: Contractor), F.Hoffman LaRoche (Institution: Contractor)

No

Jean-Paul Wolinsky

Speaker/Presenter

No relevant financial relationships to disclose.

No

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

The ACCME does not consider providers of clinical services directly to patients to be ineligible entities.

 

 

Discloser List CME Internal Report

Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

CREDIT DESIGNATION STATEMENTS

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 8.0 ANCC contact hours.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison, as a member of the University Professional Continuing Education Association (UPCEA), authorizes this program for 0.80 continuing education units (CEUs) or 8.0 hours.

Available Credit

  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 ANCC Contact Hours
  • 8.00 University of Wisconsin–Madison Continuing Education Hours
    • 8.00 Approved for AMA PRA Category 1 Credit™

Cost:
$50.00
Please login or register to take this course.

Registration Fees

$50.00 MD/DO
$25.00 Other healthcare providers
$0.00   Trainees, including fellows, residents and students

Syllabus Materials

Syllabus materials will be posted on this site.  Materials will be available to registered participants 48 hours prior to the event. If you want to view the presentations while at the conference, please bring your laptop.

ACCESSIBILITY

The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu

CANCELLATION AND REFUND POLICY

Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the $10 nonrefundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.

PROGRAM CHANGES

Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.

For Further Information

For conference information or details, please contact Mahua Dey, MD by emailing whiting@neurosurgery.wisc.edu.  

Required Hardware/software

This activity will be held live online via Webex. Please make sure you have a computer, tablet, or other device capable of video and sound.